Heart Failure Reviews

, Volume 10, Issue 1, pp 7–13

Aldosterone Biosynthesis, Regulation, and Classical Mechanism of Action

Article

Abstract

Circulating aldosterone is principally made in the glomerulosa zone of the adrenal cortex by a series of enzyme steps leading to the conversion of cholesterol to aldosterone. Uniquely, aldosterone’s production is regulated at two critical enzyme steps: (1) early in its biosynthetic pathway (the conversion of cholesterol to pregnenolone cholesterol side chain cleavage enzyme) and (2) late (the conversion of corticosterone to aldosterone by aldosterone synthase). A variety of factors modify aldosterone secretion—the most important are angiotensin II (AngII), the end-product of the renin-angiotensin system (RAS), and potassium. However ACTH, neural mediators and natriuretic factors also contribute at least over the short run. Aldosterone’s classical epithelial effect is to increase the transport of sodium across the cell in exchange for potassium and hydrogen ions. Although still controversial, there is an increasing body of data that supports the hypothesis that aldosterone can be synthesized in tissues outside of the adrenal cortex, specifically in the heart and the vasculature. Aldosterone’s biosynthesis appears to be regulated in these tissues similar to what occurs in the adrenal cortex. The role of this extra adrenal aldosterone production in health and disease is as of yet undetermined.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Mortensen RM, Williams GH. Aldosterone action. In: DeGroot LJ, Jameson JL, Burger HG, et al. eds. Endocrinology 4th ed. Philadelphia: WBSaunders, 2001:1783–1790.Google Scholar
  2. 2.
    Dluhy RG, Williams GH. Adrenal cortex. In: Kasper DL, Braunwald E, Fauci AS, et al. Eds. Harrison’s Principles of Internal Medicine 16 ed. McGraw Hill: New York, 2005;321.Google Scholar
  3. 3.
    Hollenberg NK, Chenitz WR, Adams DF, Williams GH. Reciprocal influence of salt intake on adrenal glomerulosa and renal vascular responses to angiotensin II in normal man. J Clin Invest 1974;54:34–42.PubMedGoogle Scholar
  4. 4.
    Zusman RM. Effects of converting-enzyme inhibitors on the renin-angiotensin- aldosterone, bradykinin, and arachidonic acid-prostaglandin systems: Correlation of chemical structure and biologic activity. Am J Kidney Dis 1987;10:13–23.PubMedGoogle Scholar
  5. 5.
    Whalley ET, Wahl M, Sampaio CA. Angiotensin-converting enzyme, bradykinin, angiotensin, and cerebral vessel reactivity. Hypertension 1983;5:V34–37.PubMedGoogle Scholar
  6. 6.
    Braley LM, Menachery AI, Underwood RH, Williams GH. Is the adrenal angiotensin receptor angiotensin II—or angiotensin III like? Acta Endocrinol (Copenh) 1983;102:116–121.Google Scholar
  7. 7.
    Siragy HM. AT1 and AT2 receptor in the kidney: Role in health and disease. Semin Nephrol 2004;24:93–100.PubMedGoogle Scholar
  8. 8.
    Bader M, Ganten D. Regulation of renin: New evidence from cultured cells and genetically modified mice. J Mol Med 2000;78:130–139.PubMedGoogle Scholar
  9. 9.
    Vander AJ. Effect of catecholamines and the renal nerves on renin secretion in anesthetized dogs. Am J Physiol 1965;209:659–662.PubMedGoogle Scholar
  10. 10.
    Gordon MB, Moore TJ, Dluhy RG, Williams GH. Dopaminergic blockade of the renin-angiotensin-aldosterone system: Effect of high and low sodium intakes. Clin Endocrinol (Oxf) 1983;19:415–425.Google Scholar
  11. 11.
    Goldstone R, Horton R, Carlson EJ, Hsueh WA. Reciprocal changes in active and inactive renin after converting enzyme inhibition in normal man. J Clin Endocrinol Metab 1983;56:264–268.PubMedGoogle Scholar
  12. 12.
    Seely EW, Moore TJ, Rogacz S, Gordon MS, Gleason RE, Hollenberg NK, Williams GH. Angiotensin-mediated renin suppression is altered in non-modulating hypertension. Hypertension 1989;13:31–37.PubMedGoogle Scholar
  13. 13.
    Himathongkam T, Dluhy RG, Williams GH. Potassium-aldosterone-renin interrelationships. J Clin Endocrinol Metab 1975;41:153–159.PubMedGoogle Scholar
  14. 14.
    Dluhy RG, Underwood RH, Williams GH. Influence of dietary potassium on plasma renin activity in normal man. J Appl Physiol 1970;28:299–302.PubMedGoogle Scholar
  15. 15.
    Persson AE, Ollerstam A, Liu R, Brown R. Mechanisms for macula densa cell release of renin. Acta Physiol Scand 2004;181:471–474.PubMedGoogle Scholar
  16. 16.
    Komlosi P, Fintha A, Bell PD. Current mechanisms of macula densa cell signalling. Acta Physiol Scand 2004;181:463–469.PubMedGoogle Scholar
  17. 17.
    Tuck ML, Dluhy RG, Williams GH. A specific role for saline or the sodium ion in the regulation of renin and aldosterone secretion. Journal of Clinical Investigation 1974;53:988–995.PubMedGoogle Scholar
  18. 18.
    Deschepper C, Ganong W. Renin and angiotensin in endocrine glands. In: Martini L, Ganong W, ed. Frontiers in Neuroendocrinology. New York: Raven, 1988;10.Google Scholar
  19. 19.
    Deschepper CF, Mellon SH, Cumin F, Baxter JD, Ganong WF. Analysis by immunocytochemistry and in situ hybridization of renin and its mRNA in kidney, testis, adrenal, and pituitary of the rat. Proc Nat Acad Sci USA 1986;83:7552–7556.PubMedGoogle Scholar
  20. 20.
    Kifor I, Moore TJ, Fallo F, Sperling E, Menachery A, Chiou CY, et al. The effect of sodium intake on angiotensin content of the rat adrenal gland. Endocrinology 1991;128:1277–1284.PubMedGoogle Scholar
  21. 21.
    Kifor I, Moore TJ, Fallo F, Sperling E, Chiou CY, Menachery A, et al. Potassium-stimulated angiotensin release from superfused adrenal capsules and enzymatically dispersed cells of the zona glomerulosa. Endocrinology 1991;129:823–831.PubMedGoogle Scholar
  22. 22.
    Oda H, Lotshaw DP, Franco SR, Mulrow PJ. Local generation of angiotensin II as a mechanism of aldosterone secretion in rat adrenal capsules. Proc Soc Exp Biol Med 1991;196:175–177.PubMedGoogle Scholar
  23. 23.
    Doi Y, Atarashi K, Franco SR, Mulrow PJ. Effect of changes in sodium or potassium balance, and nephrectomy, on adrenal renin and aldosterone concentrations. Hypertension 1984;6:I124–129.PubMedGoogle Scholar
  24. 24.
    Mizuno K, Hoffman LH, McKenzie JC, Inagami T. Presence of renin secretory granules in rat adrenal gland and stimulation of renin secretion by angiotensin II but not by adrenocorticotropin. J Clin Invest 1988;82:1007–1016.PubMedGoogle Scholar
  25. 25.
    Menachery A, Braley LM, Kifor I, Gleason R, Williams GH. Dissociation in plasma renin and adrenal ANG II and aldosterone responses to sodium restriction in rats. Am J Physiol 1991;261:E487–E494.PubMedGoogle Scholar
  26. 26.
    DeFronzo RA, Felig P, Ferrannini E, Wahren J. Effect of graded doses of insulin on splanchnic and peripheral potassium metabolism in man. Am J Physiol 1980;238:E421–E427.PubMedGoogle Scholar
  27. 27.
    Rosa RM, Silva P, Young JB, Landsberg L, Brown RS, Rowe JW, et al. Adrenergic modulation of extrarenal potassium disposal. N Engl J Med 1980;302:431–434.PubMedGoogle Scholar
  28. 28.
    Bia MJ, Lu D, Tyler K, De FR. Beta adrenergic control of extrarenal potassium disposal. A beta-2 mediated phenomenon. Nephron 1986;43:117–122.PubMedGoogle Scholar
  29. 29.
    Young DB. Quantitative analysis of aldosterone’s role in potassium regulation. Am J Physiol 1988;55:F811–F822.Google Scholar
  30. 30.
    Seely EW, Conlin PR, Brent GA, Dluhy RG. Adrenocorticotropin stimulation of aldosterone: Prolonged continuous versus pulsatile infusion. J Clin Endocrinol Metab 1989;69:1028–1032.PubMedGoogle Scholar
  31. 31.
    Williams GH, Rose LI, Dluhy RG, Dingman JF, Lauler DP. Aldosterone response to sodium restriction and ACTH stimulation in panhypopituitarism. J Clin Endo Metab 1971;32:27–35.Google Scholar
  32. 32.
    Ganguly A, Hampton T. Calcium-dependence of serotonin-mediated aldosterone secretion and differential effects of calcium antagonists. Life Sci 1985;36:1459–1464.PubMedGoogle Scholar
  33. 33.
    Hinson JP, Kapas S, Teja R, Vinson GP. Effect of the endothelins on aldosterone secretion by rat zona glomerulosa cells in vitro. J Steroid Biochem Mol Bio 1991;40:437–439.Google Scholar
  34. 34.
    Zeng ZP, Naruse M, Guan BJ, Naruse K, Sun ML, Zang MF, et al. Endothelin stimulates aldosterone secretion in vitro from normal adrenocortical tissue, but not adenoma tissue, in primary aldosteronism. J Clin Endo Metab 1992;74:874–878.Google Scholar
  35. 35.
    Gomez-Sanchez CE, Cozza EN, Foecking MF, Chiou S, Ferris MW. Endothelin receptor subtypes and stimulation of aldosterone secretion. Hypertension 1990;15:744–747.PubMedGoogle Scholar
  36. 36.
    Tremblay A, Waterman MR, Parker KL, Lehoux JG. Regulation of rat adrenal messenger RNA and protein levels for cytochrome P-450s and adrenodoxin by dietary sodium depletion or potassium intake. J Biol Chem 1991;266:2245–2251.PubMedGoogle Scholar
  37. 37.
    Hollenberg NK, Chenitz WR, Adams DF, Williams GH. Reciprocal influence of salt intake on adrenal glomerulosa and renal vascular responses to angiotensin II in normal man. J Clin Invest 1974;54:34–42.PubMedGoogle Scholar
  38. 38.
    Hollenberg NK, Williams G, Burger B, Hooshmand I. The influence of potassium on the renal vasculature and the adrenal gland, and their responsiveness to angiotensin II in normal man. Clin Sci Mol Med 1975;49:527–534.PubMedGoogle Scholar
  39. 39.
    Williams GH, Dluhy RG, Underwood RH. The relationship of dietary potassium intake to the aldosterone stimulating properties of ACTH. Clin Sci 1970;39:489–496.PubMedGoogle Scholar
  40. 40.
    Rogacz S, Williams GH, Hollenberg NK. Time course of enhanced adrenal responsiveness to angiotensin on a low salt diet. Hypertension 1990;15:376–380.PubMedGoogle Scholar
  41. 41.
    Williams GH, Hollenberg NK, Braley LM. Influence of sodium intake on vascular and adrenal angiotensin II receptors. Endocrinology 1976;98:1343–1350.PubMedGoogle Scholar
  42. 42.
    Williams GH, Fisher ND, Hunt SC, Jeunemaitre X, Hopkins PN, Hollenberg NK. Effects of gender and genotype on the phenotypic expression of nonmodulating essential hypertension. Kidney Int 2000;57:1404–1407.PubMedGoogle Scholar
  43. 43.
    Doucet A, Katz AI. Mineralcorticoid receptors along the nephron: [3H]aldosterone binding in rabbit tubules. Am J Physiol 1981;241:F605–F611.PubMedGoogle Scholar
  44. 44.
    Farman N, Bonvalet JP. Aldosterone binding in isolated tubules. III. Autoradiography along the rat nephron. Am J Physiol 1983;245:F606–F614.PubMedGoogle Scholar
  45. 45.
    Lombes M, Farman N, Oblin ME, Baulieu EE, Bonvalet JP, Erlanger BF, et al. Immunohistochemical localization of renal mineralocorticoid receptor by using an anti-idiotypic antibody that is an internal image of aldosterone. Proc Natl Acad Sci USA 1990;87:1086–1088.PubMedGoogle Scholar
  46. 46.
    O’Neil RG, Hayhurst RA. Functional differentiation of cell types of cortical collecting duct. Am J Physiol 1985;248:F449–F453.PubMedGoogle Scholar
  47. 47.
    Knox F, Burnett JJ, Kohan D, et al. Escape from the sodium-retaining effects of mineralocorticoids. Kidney Int 1980;17:263–276.PubMedGoogle Scholar
  48. 48.
    Haas JA, Granger JP, Knox FG. Effect of renal perfusion pressure on sodium reabsorption from proximal tubules of superficial and deep nephrons. Am J Physiol 1986;250:F425–F429.PubMedGoogle Scholar
  49. 49.
    Gonzalez-Campoy JM, Kachelski J, Burnett JJ, Romero JC, Granger JP, Knox FG. Proximal tubule response in aldosterone escape. Am J Physiol 1989;256:R86–R90.PubMedGoogle Scholar
  50. 50.
    Zimmerman RS, Edwards BS, Schwab TR, Heublein DM, Burnett JJ. Atrial natriuretic peptide during mineralocorticoid escape in the human. J Clin Endo Metab 1987;64:624–627.Google Scholar
  51. 51.
    Ballermann BJ, Bloch KD, Seidman JG, Brenner BM. Atrial natriuretic peptide transcription, secretion, and glomerular receptor activity during mineralocorticoid escape in the rat. J Clin Invest 1986;78:840–843.PubMedGoogle Scholar

Copyright information

© Springer Science + Business Media, Inc. 2005

Authors and Affiliations

  1. 1.Division of Endocrinology, Diabetes and Hypertension, Brigham and Women’s HospitalHarvard Medical SchoolBostonUSA
  2. 2.Cardiovascular Endocrinology Section, Endocrinology, Diabetes and Hypertension DivisionBrigham and Women’s HospitalBostonUSA

Personalised recommendations